Mauskopf, J A <br/><br/>
Cost-effectiveness analysis of the use of digoxin immune Fab (ovine) for treatment of digoxin toxicity.  [electronic resource] 

 -  The American journal of cardiology  Dec 1991 
 - 1709-14 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0002-9149 
<br/><br/><label>Standard No.: </label>10.1016/0002-9149(91)90334-h  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Accidents<br/>Adult<br/>Arrhythmias, Cardiac--chemically induced<br/>Cardiac Pacing, Artificial--economics<br/>Cause of Death<br/>Child, Preschool<br/>Cost-Benefit Analysis<br/>Costs and Cost Analysis<br/>Digoxin--blood<br/>Electric Countershock--economics<br/>Heart Massage--economics<br/>Humans<br/>Immunoglobulin Fab Fragments--administration & dosage<br/>Length of Stay--economics<br/>Life Expectancy<br/>Poisoning--drug therapy<br/>Probability<br/>Suicide, Attempted<br/>Survival Rate<br/>Treatment Outcome